Cellular Biomedicine Group, Inc. EPS - Earnings per Share 2010-2020 | CBMG
Cellular Biomedicine Group, Inc. eps - earnings per share from 2010 to 2020. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Cellular Biomedicine Group, Inc. Annual EPS |
| 2019 |
$-2.63 |
| 2018 |
$-2.20 |
| 2017 |
$-1.78 |
| 2016 |
$-2.09 |
| 2015 |
$-1.70 |
| 2014 |
$-1.79 |
| 2013 |
$-2.38 |
| 2012 |
$-2.24 |
| 2011 |
$-0.50 |
| 2010 |
$0.00 |
| 2009 |
$-0.01 |
| Cellular Biomedicine Group, Inc. Quarterly EPS |
| 2020-09-30 |
$-0.88 |
| 2020-06-30 |
$-0.70 |
| 2020-03-31 |
$-0.60 |
| 2019-12-31 |
$-0.67 |
| 2019-09-30 |
$-0.82 |
| 2019-06-30 |
$-0.63 |
| 2019-03-31 |
$-0.51 |
| 2018-12-31 |
$-0.44 |
| 2018-09-30 |
$-0.72 |
| 2018-06-30 |
$-0.53 |
| 2018-03-31 |
$-0.51 |
| 2017-12-31 |
$-0.49 |
| 2017-09-30 |
$-0.43 |
| 2017-06-30 |
$-0.43 |
| 2017-03-31 |
$-0.43 |
| 2016-12-31 |
$-0.47 |
| 2016-09-30 |
$-0.75 |
| 2016-06-30 |
$-0.52 |
| 2016-03-31 |
$-0.35 |
| 2015-12-31 |
$-0.43 |
| 2015-09-30 |
$-0.44 |
| 2015-06-30 |
$-0.44 |
| 2015-03-31 |
$-0.39 |
| 2014-12-31 |
$-0.57 |
| 2014-09-30 |
$-0.31 |
| 2014-06-30 |
$-0.85 |
| 2014-03-31 |
$-0.06 |
| 2013-12-31 |
$-0.87 |
| 2013-09-30 |
$0.09 |
| 2013-06-30 |
$-0.44 |
| 2013-03-31 |
$-1.16 |
| 2012-12-31 |
$-1.17 |
| 2012-09-30 |
$-0.45 |
| 2012-06-30 |
$-0.30 |
| 2012-03-31 |
$-0.32 |
| 2011-12-31 |
$-0.50 |
| 2011-09-30 |
$-0.00 |
| 2011-06-30 |
$0.00 |
| 2011-03-31 |
$0.00 |
| 2010-12-31 |
$0.00 |
| 2010-09-30 |
$0.00 |
| 2010-06-30 |
$0.00 |
| 2010-03-31 |
$0.00 |
| 2009-12-31 |
$0.00 |
| 2009-09-30 |
$0.00 |
| 2009-06-30 |
$0.00 |
| 2009-03-31 |
$0.00 |
